Skip to main content

Table 3 Clinical outcomes

From: Severe pain-related adverse events of percutaneous dilatational tracheostomy performed by a neurointensivist compared with conventional surgical tracheostomy in neurocritically ill patients

 PDT performed by a neurointensivist (n = 71)Conventional surgical method (n = 85)P value
Incidence of SAE — No. of patients (%)30 (42.3)57 (67.1)0.002
Event of SAE — No. of events (%)
 Arrhythmia13 (18.3)36 (42.4)0.001
  Tachycardia13 (18.3)34 (40.0) 
  Bradycardia0 (0)3 (3.5) 
 Hypertension13 (18.3)34 (40.0)0.003
  Use of the antihypertensive drug during the procedure7 (9.9)11 (12.9)0.728
 Ventilator distress0 (0)10 (11.8)0.008
 Hypotension1 (1.4)5 (5.9)0.303
 Desaturation0 (0)4 (4.7)0.179
 Arrest0 (0)2 (2.4)0.558
 Bradypnea0 (0)1 (1.2)0.999
 Use of hyperosmolar agent during procedure0 (0)3 (3.5)0.311
Duration of total SAE (min) — mean ± SD3.4 ± 5.319.8 ± 23.0< 0.001
Procedural data
 Initial success of tracheostomy — No. of patients (%)71 (100)81 (95.3)0.179
 Procedure time (min) — mean ± SD17.7 ± 9.242.2 ± 21.8< 0.001
Outcomes
 ICU mortality — No. of patients (%)2 (2.8)1 (1.2)0.187
 Hospital mortality — No. of patients (%)6 (8.5)9 (10.6)0.651
 Length of stay in ICU (days) — mean ± SD17.35 ± 13.218.11 ± 18.40.773
 Length of stay in hospital (days) — mean ± SD78.74 ± 117.179.06 ± 136.20.988
  1. SAE severe pain-related adverse events, PDT Percutaneous dilatational tracheostomy, SD standard deviation, ICU intensive care unit
\